Health Canada approves new hep C treatment drug Sovaldi (Sofosbuvir)

Pacific Hep C_logo


In December 2013,  Health Canada approved Sovaldi (sofosbuvir) for use in Canada. As a new HCV treatment drug, sofosbuvir offers great promise  for shorter treatment times, and the convenience of taking one pill a day. This new treatment  drug has the potential to be effective without interferon (depending on genotype) however, treatment still involves interferon and ribavirin.

Continue reading